Skip to main content
Erschienen in: Pediatric Cardiology 6/2009

01.08.2009 | Original Article

Comparison of Vascular Complications Between Conventional Treatment and Bone Marrow Transplantation for Children with ß-Thalassemia Disease

verfasst von: Alisa Limsuwan, Darin Tubtom, Samart Pakakasama, Ampiwan Chaunsumrit

Erschienen in: Pediatric Cardiology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Patients with ß-thalassemia may be predisposed to premature atherosclerosis due to vascular dysfunction. This is observed in adults. Whether atherosclerosis changes in ß-thalassemia disease (BTD) occur early in childhood is not clear. To prevent cardiovascular complications, this needs evaluation. Moreover, it remains uncertain whether curative treatment with bone marrow transplantation (BMT) would improve this vascular alteration. For this study, 37 ß-thalassemia children age 10.1 ± 2.7 years were classified into group 1 (25 children with BTD treated conventionally) and group 2 (12 children with BTD who underwent BMT). A control group of 29 age-matched healthy children were studied simultaneously. The carotid stiffness index and intima–media thickness (IMT) were measured. Group1 had a greater arterial stiffness index than the control subjects (4.57 ± 1.78 vs. 2.87 ± 1.07; p < 0.001). The carotid IMT was significantly greater in both BTD groups than in the control group (group 1: 0.45 ± 0.03 vs. 0.34 ± 0.04 mm; p < 0.001; group 2: 0.43 ± 0.03 vs. 0.34 ± 0.04 mm; p < 0.001). Carotid IMT and arterial stiffness are increased in conventionally treated children with ß-thalassemia, suggesting an early atherosclerotic change in these children, whereas children with BTD who underwent BMT had an increased carotid IMT but normal arterial stiffness.
Literatur
1.
Zurück zum Zitat Aessopos A, Farmakis D, Loukopoulos D (2002) Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood 99:30–35PubMedCrossRef Aessopos A, Farmakis D, Loukopoulos D (2002) Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood 99:30–35PubMedCrossRef
2.
Zurück zum Zitat Aggeli C, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, Ladis V, Karageorga M, Pitsavos C, Stefanadis C (2005) Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol 105:80–84PubMedCrossRef Aggeli C, Antoniades C, Cosma C, Chrysohoou C, Tousoulis D, Ladis V, Karageorga M, Pitsavos C, Stefanadis C (2005) Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol 105:80–84PubMedCrossRef
3.
Zurück zum Zitat Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM (1991) Hemin: a possible physiological mediator of low-density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 11:1700–1711PubMed Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM (1991) Hemin: a possible physiological mediator of low-density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 11:1700–1711PubMed
4.
Zurück zum Zitat Bellocq A, Israel-Biet D, Cadranel J, Perez J, Fouqueray B, Kanfer A, Girot R, Baud L (1999) Reduction of tumour necrosis factor alpha expression and signalling in peripheral blood mononuclear cells from patients with thalassaemia or sickle cell anaemia upon treatment with desferrioxamine. Cytokine 11:168–172PubMedCrossRef Bellocq A, Israel-Biet D, Cadranel J, Perez J, Fouqueray B, Kanfer A, Girot R, Baud L (1999) Reduction of tumour necrosis factor alpha expression and signalling in peripheral blood mononuclear cells from patients with thalassaemia or sickle cell anaemia upon treatment with desferrioxamine. Cytokine 11:168–172PubMedCrossRef
5.
Zurück zum Zitat Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR, Sabato V, Melevendi C, Cappellini MD, Verlato G (1998) Survival and disease complications in thalassemia major. Ann N Y Acad Sci 850:227–231PubMedCrossRef Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR, Sabato V, Melevendi C, Cappellini MD, Verlato G (1998) Survival and disease complications in thalassemia major. Ann N Y Acad Sci 850:227–231PubMedCrossRef
6.
Zurück zum Zitat Cheung YF, Chan GC, Ha SY (2002) Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 106:2561–2566PubMedCrossRef Cheung YF, Chan GC, Ha SY (2002) Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 106:2561–2566PubMedCrossRef
7.
Zurück zum Zitat Cheung YF, Chow PC, Chan GC, Ha SY (2006) Carotid intima–media thickness is increased and related to arterial stiffening in patients with beta-thalassaemia major. Br J Haematol 135:732–734PubMedCrossRef Cheung YF, Chow PC, Chan GC, Ha SY (2006) Carotid intima–media thickness is increased and related to arterial stiffening in patients with beta-thalassaemia major. Br J Haematol 135:732–734PubMedCrossRef
8.
Zurück zum Zitat Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP (2003) Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107:2601–2606PubMed Day SM, Duquaine D, Mundada LV, Menon RG, Khan BV, Rajagopalan S, Fay WP (2003) Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107:2601–2606PubMed
9.
Zurück zum Zitat Del Vecchio GC, Schettini F, Piacente L, De Santis A, Giordano P, De Mattia D (2002) Effects of deferiprone on immune status and cytokine pattern in thalassaemia major. Acta Haematol 108:144–149PubMedCrossRef Del Vecchio GC, Schettini F, Piacente L, De Santis A, Giordano P, De Mattia D (2002) Effects of deferiprone on immune status and cytokine pattern in thalassaemia major. Acta Haematol 108:144–149PubMedCrossRef
10.
11.
Zurück zum Zitat Hahalis G, Kremastinos DT, Terzis G, Kalogeropoulos AP, Chrysanthopoulou A, Karakantza M, Kourakli A, Adamopoulos S, Tselepis AD, Grapsas N, Siablis D, Zoumbos NC, Alexopoulos D (2008) Global vasomotor dysfunction and accelerated vascular aging in beta-thalassemia major. Atherosclerosis 198:448–457PubMedCrossRef Hahalis G, Kremastinos DT, Terzis G, Kalogeropoulos AP, Chrysanthopoulou A, Karakantza M, Kourakli A, Adamopoulos S, Tselepis AD, Grapsas N, Siablis D, Zoumbos NC, Alexopoulos D (2008) Global vasomotor dysfunction and accelerated vascular aging in beta-thalassemia major. Atherosclerosis 198:448–457PubMedCrossRef
12.
Zurück zum Zitat Kremastinos DT, Flevari P, Spyropoulou M, Vrettou H, Tsiapras D, Stavropoulos-Giokas CG (1999) Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex. Circulation 100:2074–2078PubMed Kremastinos DT, Flevari P, Spyropoulou M, Vrettou H, Tsiapras D, Stavropoulos-Giokas CG (1999) Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex. Circulation 100:2074–2078PubMed
13.
Zurück zum Zitat Kunsch C, Medford RM (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85:753–766PubMed Kunsch C, Medford RM (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85:753–766PubMed
14.
Zurück zum Zitat Kyriakou DS, Alexandrakis MG, Kyriakou ES, Liapi D, Kourelis TV, Passam F, Papadakis A (2001) Activated peripheral blood and endothelial cells in thalassemia patients. Ann Hematol 80:577–583PubMedCrossRef Kyriakou DS, Alexandrakis MG, Kyriakou ES, Liapi D, Kourelis TV, Passam F, Papadakis A (2001) Activated peripheral blood and endothelial cells in thalassemia patients. Ann Hematol 80:577–583PubMedCrossRef
15.
Zurück zum Zitat Lombardi G, Matera R, Minervini MM, Cascavilla N, D’Arcangelo P, Carotenuto M, Di Giorgio G, Musto P (1994) Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status. Haematologica 79:406–412PubMed Lombardi G, Matera R, Minervini MM, Cascavilla N, D’Arcangelo P, Carotenuto M, Di Giorgio G, Musto P (1994) Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: relationship to immune status. Haematologica 79:406–412PubMed
16.
Zurück zum Zitat Mancini GB, Dahlof B, Diez J (2004) Surrogate markers for cardiovascular disease: Structural markers. Circulation 109(25 Suppl 1):IV22–IV30PubMed Mancini GB, Dahlof B, Diez J (2004) Surrogate markers for cardiovascular disease: Structural markers. Circulation 109(25 Suppl 1):IV22–IV30PubMed
17.
Zurück zum Zitat Neri A, Callea V, D’Ascola DG, Martino B (1986) Immune status in thalassemia major. Haematologica 71:511–516PubMed Neri A, Callea V, D’Ascola DG, Martino B (1986) Immune status in thalassemia major. Haematologica 71:511–516PubMed
18.
Zurück zum Zitat O’Rourke M (1995) Mechanical principles in arterial disease. Hypertension 26:2–9PubMed O’Rourke M (1995) Mechanical principles in arterial disease. Hypertension 26:2–9PubMed
19.
Zurück zum Zitat Pratico D, Pasin M, Barry OP, Ghiselli A, Sabatino G, Iuliano L, FitzGerald GA, Violi F (1999) Iron-dependent human platelet activation and hydroxyl radical formation: Involvement of protein kinase C. Circulation 99:3118–3124PubMed Pratico D, Pasin M, Barry OP, Ghiselli A, Sabatino G, Iuliano L, FitzGerald GA, Violi F (1999) Iron-dependent human platelet activation and hydroxyl radical formation: Involvement of protein kinase C. Circulation 99:3118–3124PubMed
20.
Zurück zum Zitat Rougier F, Cornu E, Praloran V, Denizot Y (1998) IL-6 and IL-8 production by human bone marrow stromal cells. Cytokine 10:93–97PubMedCrossRef Rougier F, Cornu E, Praloran V, Denizot Y (1998) IL-6 and IL-8 production by human bone marrow stromal cells. Cytokine 10:93–97PubMedCrossRef
21.
Zurück zum Zitat Salsaa B, Zoumbos NC (1997) A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with beta-thalassaemia. Clin Exp Immunol 107:589–592PubMedCrossRef Salsaa B, Zoumbos NC (1997) A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with beta-thalassaemia. Clin Exp Immunol 107:589–592PubMedCrossRef
22.
Zurück zum Zitat Scaccabarozzi A, Arosio P, Weiss G, Valenti L, Dongiovanni P, Fracanzani AL, Mattioli M, Levi S, Fiorelli G, Fargion S (2000) Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br J Haematol 110:978–984PubMedCrossRef Scaccabarozzi A, Arosio P, Weiss G, Valenti L, Dongiovanni P, Fracanzani AL, Mattioli M, Levi S, Fiorelli G, Fargion S (2000) Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br J Haematol 110:978–984PubMedCrossRef
23.
Zurück zum Zitat Schechter AN, Gladwin MT (2003) Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med 348:1483–1485PubMedCrossRef Schechter AN, Gladwin MT (2003) Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med 348:1483–1485PubMedCrossRef
24.
Zurück zum Zitat Tsomi K, Karagiorga-Lagana M, Fragodimitri C, Karabatsos F, Katsiki V (1999) Arterial elastorrhexis: Manifestation of a generalized elastic tissue disorder in beta-thalassaemia major. Eur J Haematol 63:287–294PubMedCrossRef Tsomi K, Karagiorga-Lagana M, Fragodimitri C, Karabatsos F, Katsiki V (1999) Arterial elastorrhexis: Manifestation of a generalized elastic tissue disorder in beta-thalassaemia major. Eur J Haematol 63:287–294PubMedCrossRef
Metadaten
Titel
Comparison of Vascular Complications Between Conventional Treatment and Bone Marrow Transplantation for Children with ß-Thalassemia Disease
verfasst von
Alisa Limsuwan
Darin Tubtom
Samart Pakakasama
Ampiwan Chaunsumrit
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 6/2009
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-009-9436-z

Weitere Artikel der Ausgabe 6/2009

Pediatric Cardiology 6/2009 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.